Riskpilot← Back to searchSign inGet full accessRT Skopikonsult AB
ABActiveOrg 5591113229Havsörnsvägen 70Medical specialists activities · NACE 8622Est. 20172 employees
Revenue 2025
SEK 986K
-51% vs 2024
EBITDA margin
53.8%
-62% vs 2024
Equity ratio
82.8%
Financial strength
Net profit 2025
SEK 612K
-26% vs 2024
| Revenue | SEK 986K | -51% |
| EBITDA | SEK 530K | -62% |
| Net profit | SEK 612K | -26% |
| Total assets | SEK 5,2M | +5% |
| Equity | SEK 4,3M | +11% |
| Employees | 2 | — |
Legal name
RT Skopikonsult AB
Org number
5591113229
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
8 maj 2017
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall utveckla, stödja och förbättra medicinsk verksamhet och bedriva kvalificerad vård inom specialistsjukvård samt utveckla friskvård, motions- och elitidrott och därmed förenlig verksamhet. Vidare skall bolaget äga fastigheter och förvalta värdepapper och kapital samt därtill förenlig verksamhet.
Address
Havsörnsvägen 70
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 024 | 970 | 2 008 | 1 999 | 986 |
| Staff expenses | — | −61 | −10 | −31 | — |
| EBITDA | 739 | 642 | 1 576 | 1 405 | 530 |
| Depreciation & amort. | −8 | −8 | −20 | −115 | −8 |
| EBIT | 731 | 635 | 1 557 | 1 291 | 522 |
| Net financials | −9 | — | 54 | 39 | 259 |
| Profit before tax | 677 | 868 | 1 330 | 1 055 | 782 |
| Tax | −150 | −193 | −282 | −228 | −170 |
| Net profit | 527 | 674 | 1 049 | 826 | 612 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 857 | 2 888 | 4 138 | 4 898 | 5 160 |
| Equity | 1 964 | 2 455 | 3 316 | 3 867 | 4 274 |
| Long-term debt | 307 | 99 | 107 | 29 | 6 |
| Short-term debt | 89 | 70 | 170 | 182 | 59 |
| Total debt | 396 | 169 | 277 | 211 | 65 |
EBITDA margin
53.8%
This company
15.8%
Market median
+241% vs market
20212025
Equity ratio
82.8%
This company
38.2%
Market median
+117% vs market
20212025
Return on equity
14.3%
This company
18.4%
Market median
+22% vs market
20212025
Net profit margin
62.1%
This company
8.1%
Market median
+667% vs market
20212025
Asset turnover
0.19×
This company
1.12×
Market median
-83% vs market
20212025
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Chairman | 2022 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RT Skopikonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lennart Stefan Klingberg | Deputy Board Member | 0 companies |
| Ylva Cecilia Ottosson Tour | Board of Directors | 0 companies |
| René Lennart Tour | Chairman | 0 companies |
| Katarina Cecilia Tour | Deputy Board Member | 0 companies |